Company Filing History:
Years Active: 2011
Title: Mohammed Sharief: Innovator in Neurodegenerative Treatment
Introduction
Mohammed Sharief is a notable inventor based in Kent, GB. He has made significant contributions to the field of neurodegenerative disease treatment, holding two patents that showcase his innovative approaches. His work focuses on the therapeutic use of lipid glycerides and triglyceride oils to improve patient outcomes.
Latest Patents
Sharief's latest patents include a method for treating neurodegenerative conditions. This method involves administering a therapeutically effective dose of a lipid glyceride that contains a glycerol moiety and a fatty acid moiety. The fatty acid moiety is specifically selected from gamma-linolenic acid, dihomo-gamma-linolenic acid, and arachidonic acid. The unique aspect of this method is that the selected fatty acid moiety is attached to the glycerol moiety at its sn-2 position. The treatment aims to maintain or elevate TGF-β1 levels in patients to therapeutic levels.
Another patent focuses on the use of triglyceride oils containing gamma-linolenic acid and linoleic acid residues for treating neurodegenerative diseases. This method requires administering a therapeutically effective dose of a triglyceride oil that has a specific ratio of gamma-linolenic acid to linolenic acid residues at the sn-2 position. The oil is administered at a dose sufficient to maintain or elevate TGF-β1 levels in the patient at a therapeutic level.
Career Highlights
Sharief is currently associated with Btg International Limited, where he continues to develop innovative treatments for neurodegenerative conditions. His work has garnered attention for its potential to improve the quality of life for patients suffering from these challenging diseases.
Collaborations
Some of his notable coworkers include Laurence Harbige and Michael J Leach. Their collaboration has contributed to the advancement of research in the field of neurodegenerative treatments.
Conclusion
Mohammed Sharief's innovative work in the treatment of neurodegenerative diseases highlights the importance of research and development in healthcare. His patents reflect a commitment to improving patient outcomes through novel therapeutic methods.